Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million
Morbidity and costs after pancreatoduodenectomy remain increased, driven by postoperative pancreatic fistula (POPF). A risk-based pathway for pancreatoduodenectomy (RBP-PD) was implemented and the clinical and cost outcomes compared with that of our historic practice. Prospective clinical and cost o...
Gespeichert in:
| Veröffentlicht in: | Surgery 2018-03, Vol.163 (3), p.495-502 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 502 |
|---|---|
| container_issue | 3 |
| container_start_page | 495 |
| container_title | Surgery |
| container_volume | 163 |
| creator | Shubert, Christopher R. Kendrick, Michael L. Habermann, Elizabeth B. Glasgow, Amy E. Borah, Bijan J. Moriarty, James P. Cleary, Sean P. Smoot, Rory L. Farnell, Michael B. Nagorney, David M. Truty, Mark J. Que, Florencia G. |
| description | Morbidity and costs after pancreatoduodenectomy remain increased, driven by postoperative pancreatic fistula (POPF). A risk-based pathway for pancreatoduodenectomy (RBP-PD) was implemented and the clinical and cost outcomes compared with that of our historic practice.
Prospective clinical and cost outcomes for our RBP-PD cohort treated from September 2014 to September 2015 were compared with a previously published cohort of pancreatoduodenectomies from January 2007 to February 2014.
A total of 128 RBP-PD cases were compared with 808 historic controls. Apart from less blood loss, there were no significant clinical differences between the 2 groups. Overall POPF rate did not change. Average duration of stay decreased to 10 days from 12 (P |
| doi_str_mv | 10.1016/j.surg.2017.10.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1980103312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606017307213</els_id><sourcerecordid>1980103312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-9c1f9837062715433e555b66a7e1a261fe52527cb01d554b8d6607bd9ddbafff3</originalsourceid><addsrcrecordid>eNp9Uc2OFCEYJEbjjqsv4MFw8OBhe-RnoKcTL2aj6yabeNEzoeFjZaShBXrMPJMvKZ1Z9-iJjy9VRVGF0GtKtpRQ-f6wLUu-3zJC-7bYEsaeoA0VnHU9l_Qp2hDCh04SSS7Qi1IOhJBhR_fP0QUbWC-GfrdBf26nOcAEserqU8TJ4TmnMoOp_ghXeH0BUuxsbtd4hbMvP7tRF7B41vXHb33CLuU2R5NB12SXZCE2dppOOENZQi3YR-ynJntsLBN89EYHnJZq0gQF62ix87lUfAKdsUltKvro431Z7bylePIhNHMv0TOnQ4FXD-cl-v7507frL93d15vb6493neFC1m4w1A173hPJeip2nIMQYpRS90A1k9SBYIL1ZiTUCrEb91ZK0o92sHbUzjl-id6ddZvlXwuUqiZfDISgI6SlKDrsCSWcU9ag7Aw1LbSSwak5-0nnk6JErSWpg1ojVGtJ666V1EhvHvSXcQL7SPnXSgN8OAOg_fLoIatiPEQD1ucWrbLJ_0__L7vpp9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1980103312</pqid></control><display><type>article</type><title>Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million</title><source>Access via ScienceDirect (Elsevier)</source><creator>Shubert, Christopher R. ; Kendrick, Michael L. ; Habermann, Elizabeth B. ; Glasgow, Amy E. ; Borah, Bijan J. ; Moriarty, James P. ; Cleary, Sean P. ; Smoot, Rory L. ; Farnell, Michael B. ; Nagorney, David M. ; Truty, Mark J. ; Que, Florencia G.</creator><creatorcontrib>Shubert, Christopher R. ; Kendrick, Michael L. ; Habermann, Elizabeth B. ; Glasgow, Amy E. ; Borah, Bijan J. ; Moriarty, James P. ; Cleary, Sean P. ; Smoot, Rory L. ; Farnell, Michael B. ; Nagorney, David M. ; Truty, Mark J. ; Que, Florencia G.</creatorcontrib><description>Morbidity and costs after pancreatoduodenectomy remain increased, driven by postoperative pancreatic fistula (POPF). A risk-based pathway for pancreatoduodenectomy (RBP-PD) was implemented and the clinical and cost outcomes compared with that of our historic practice.
Prospective clinical and cost outcomes for our RBP-PD cohort treated from September 2014 to September 2015 were compared with a previously published cohort of pancreatoduodenectomies from January 2007 to February 2014.
A total of 128 RBP-PD cases were compared with 808 historic controls. Apart from less blood loss, there were no significant clinical differences between the 2 groups. Overall POPF rate did not change. Average duration of stay decreased to 10 days from 12 (P < .001) despite similar readmission rates. Postsurgical interventional radiology procedures decreased to 18.0% from 26.4% (P = .048). Utilization of and duration of stay in monitored care decreased to 23.4% from 35.6% (P < .01) and to 1 day from 3 (P < .01). On multivariable analysis RBP-PD was independently associated with decreased odds of higher postoperative pancreatic fistula grade, monitored care, and prolonged duration of stay. Inpatient cost of care decreased $6,387 per patient (–11.1%, P = .016), and total 30-day costs decreased $8,565 per patient (–13.7%, P = .01), representing a total 30-day cost savings of $1.1 million.
RBP-PD significantly improved patient outcomes, decreased costs of care, and likely has applicability for surgical care beyond pancreatoduodenectomy.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2017.10.022</identifier><identifier>PMID: 29275974</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Surgery, 2018-03, Vol.163 (3), p.495-502</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-9c1f9837062715433e555b66a7e1a261fe52527cb01d554b8d6607bd9ddbafff3</citedby><cites>FETCH-LOGICAL-c356t-9c1f9837062715433e555b66a7e1a261fe52527cb01d554b8d6607bd9ddbafff3</cites><orcidid>0000-0001-6472-2350</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.surg.2017.10.022$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29275974$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shubert, Christopher R.</creatorcontrib><creatorcontrib>Kendrick, Michael L.</creatorcontrib><creatorcontrib>Habermann, Elizabeth B.</creatorcontrib><creatorcontrib>Glasgow, Amy E.</creatorcontrib><creatorcontrib>Borah, Bijan J.</creatorcontrib><creatorcontrib>Moriarty, James P.</creatorcontrib><creatorcontrib>Cleary, Sean P.</creatorcontrib><creatorcontrib>Smoot, Rory L.</creatorcontrib><creatorcontrib>Farnell, Michael B.</creatorcontrib><creatorcontrib>Nagorney, David M.</creatorcontrib><creatorcontrib>Truty, Mark J.</creatorcontrib><creatorcontrib>Que, Florencia G.</creatorcontrib><title>Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Morbidity and costs after pancreatoduodenectomy remain increased, driven by postoperative pancreatic fistula (POPF). A risk-based pathway for pancreatoduodenectomy (RBP-PD) was implemented and the clinical and cost outcomes compared with that of our historic practice.
Prospective clinical and cost outcomes for our RBP-PD cohort treated from September 2014 to September 2015 were compared with a previously published cohort of pancreatoduodenectomies from January 2007 to February 2014.
A total of 128 RBP-PD cases were compared with 808 historic controls. Apart from less blood loss, there were no significant clinical differences between the 2 groups. Overall POPF rate did not change. Average duration of stay decreased to 10 days from 12 (P < .001) despite similar readmission rates. Postsurgical interventional radiology procedures decreased to 18.0% from 26.4% (P = .048). Utilization of and duration of stay in monitored care decreased to 23.4% from 35.6% (P < .01) and to 1 day from 3 (P < .01). On multivariable analysis RBP-PD was independently associated with decreased odds of higher postoperative pancreatic fistula grade, monitored care, and prolonged duration of stay. Inpatient cost of care decreased $6,387 per patient (–11.1%, P = .016), and total 30-day costs decreased $8,565 per patient (–13.7%, P = .01), representing a total 30-day cost savings of $1.1 million.
RBP-PD significantly improved patient outcomes, decreased costs of care, and likely has applicability for surgical care beyond pancreatoduodenectomy.</description><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9Uc2OFCEYJEbjjqsv4MFw8OBhe-RnoKcTL2aj6yabeNEzoeFjZaShBXrMPJMvKZ1Z9-iJjy9VRVGF0GtKtpRQ-f6wLUu-3zJC-7bYEsaeoA0VnHU9l_Qp2hDCh04SSS7Qi1IOhJBhR_fP0QUbWC-GfrdBf26nOcAEserqU8TJ4TmnMoOp_ghXeH0BUuxsbtd4hbMvP7tRF7B41vXHb33CLuU2R5NB12SXZCE2dppOOENZQi3YR-ynJntsLBN89EYHnJZq0gQF62ix87lUfAKdsUltKvro431Z7bylePIhNHMv0TOnQ4FXD-cl-v7507frL93d15vb6493neFC1m4w1A173hPJeip2nIMQYpRS90A1k9SBYIL1ZiTUCrEb91ZK0o92sHbUzjl-id6ddZvlXwuUqiZfDISgI6SlKDrsCSWcU9ag7Aw1LbSSwak5-0nnk6JErSWpg1ojVGtJ666V1EhvHvSXcQL7SPnXSgN8OAOg_fLoIatiPEQD1ucWrbLJ_0__L7vpp9A</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Shubert, Christopher R.</creator><creator>Kendrick, Michael L.</creator><creator>Habermann, Elizabeth B.</creator><creator>Glasgow, Amy E.</creator><creator>Borah, Bijan J.</creator><creator>Moriarty, James P.</creator><creator>Cleary, Sean P.</creator><creator>Smoot, Rory L.</creator><creator>Farnell, Michael B.</creator><creator>Nagorney, David M.</creator><creator>Truty, Mark J.</creator><creator>Que, Florencia G.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6472-2350</orcidid></search><sort><creationdate>20180301</creationdate><title>Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million</title><author>Shubert, Christopher R. ; Kendrick, Michael L. ; Habermann, Elizabeth B. ; Glasgow, Amy E. ; Borah, Bijan J. ; Moriarty, James P. ; Cleary, Sean P. ; Smoot, Rory L. ; Farnell, Michael B. ; Nagorney, David M. ; Truty, Mark J. ; Que, Florencia G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-9c1f9837062715433e555b66a7e1a261fe52527cb01d554b8d6607bd9ddbafff3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shubert, Christopher R.</creatorcontrib><creatorcontrib>Kendrick, Michael L.</creatorcontrib><creatorcontrib>Habermann, Elizabeth B.</creatorcontrib><creatorcontrib>Glasgow, Amy E.</creatorcontrib><creatorcontrib>Borah, Bijan J.</creatorcontrib><creatorcontrib>Moriarty, James P.</creatorcontrib><creatorcontrib>Cleary, Sean P.</creatorcontrib><creatorcontrib>Smoot, Rory L.</creatorcontrib><creatorcontrib>Farnell, Michael B.</creatorcontrib><creatorcontrib>Nagorney, David M.</creatorcontrib><creatorcontrib>Truty, Mark J.</creatorcontrib><creatorcontrib>Que, Florencia G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shubert, Christopher R.</au><au>Kendrick, Michael L.</au><au>Habermann, Elizabeth B.</au><au>Glasgow, Amy E.</au><au>Borah, Bijan J.</au><au>Moriarty, James P.</au><au>Cleary, Sean P.</au><au>Smoot, Rory L.</au><au>Farnell, Michael B.</au><au>Nagorney, David M.</au><au>Truty, Mark J.</au><au>Que, Florencia G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>163</volume><issue>3</issue><spage>495</spage><epage>502</epage><pages>495-502</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><abstract>Morbidity and costs after pancreatoduodenectomy remain increased, driven by postoperative pancreatic fistula (POPF). A risk-based pathway for pancreatoduodenectomy (RBP-PD) was implemented and the clinical and cost outcomes compared with that of our historic practice.
Prospective clinical and cost outcomes for our RBP-PD cohort treated from September 2014 to September 2015 were compared with a previously published cohort of pancreatoduodenectomies from January 2007 to February 2014.
A total of 128 RBP-PD cases were compared with 808 historic controls. Apart from less blood loss, there were no significant clinical differences between the 2 groups. Overall POPF rate did not change. Average duration of stay decreased to 10 days from 12 (P < .001) despite similar readmission rates. Postsurgical interventional radiology procedures decreased to 18.0% from 26.4% (P = .048). Utilization of and duration of stay in monitored care decreased to 23.4% from 35.6% (P < .01) and to 1 day from 3 (P < .01). On multivariable analysis RBP-PD was independently associated with decreased odds of higher postoperative pancreatic fistula grade, monitored care, and prolonged duration of stay. Inpatient cost of care decreased $6,387 per patient (–11.1%, P = .016), and total 30-day costs decreased $8,565 per patient (–13.7%, P = .01), representing a total 30-day cost savings of $1.1 million.
RBP-PD significantly improved patient outcomes, decreased costs of care, and likely has applicability for surgical care beyond pancreatoduodenectomy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>29275974</pmid><doi>10.1016/j.surg.2017.10.022</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-6472-2350</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0039-6060 |
| ispartof | Surgery, 2018-03, Vol.163 (3), p.495-502 |
| issn | 0039-6060 1532-7361 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1980103312 |
| source | Access via ScienceDirect (Elsevier) |
| title | Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T09%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20of%20prospective,%20surgeon-driven,%20risk-based%20pathway%20for%20pancreatoduodenectomy%20results%20in%20improved%20clinical%20outcomes%20and%20first%20year%20cost%20savings%20of%20$1%20million&rft.jtitle=Surgery&rft.au=Shubert,%20Christopher%20R.&rft.date=2018-03-01&rft.volume=163&rft.issue=3&rft.spage=495&rft.epage=502&rft.pages=495-502&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2017.10.022&rft_dat=%3Cproquest_cross%3E1980103312%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1980103312&rft_id=info:pmid/29275974&rft_els_id=S0039606017307213&rfr_iscdi=true |